Evidence of alternate mechanisms of HRD including small mutations in BARD1, homozygous loss of RAD51 paralogs and overexpression of RECQL5 indicate the complex nature of HRD, and illustrate the benefit of comprehensive genomic profiling to identify HRD patients. This evidence concerns the gene RECQL5 and hypoparathyroidism-retardation-dysmorphism syndrome.